Ticker Details
Vir Biotechnology, Inc.
IPO Date:	October 11, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.57B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.81 | 3.12%
Avg Daily Range (30 D):	$0.25 | 2.76%
Avg Daily Range (90 D):	$0.23 | 3.10%

Institutional Daily Volume
Avg Daily Volume:	1.07M
Avg Daily Volume (30 D):	2.95M
Avg Daily Volume (90 D):	2.57M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	108
Avg Trade Size (Sh.) (90 D):	104

Institutional Trades
Total Institutional Trades:	3,209
Avg Institutional Trade:	$2.43M
Avg Institutional Trade (30 D):	$2.35M
Avg Institutional Trade (90 D):	$1.81M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.46M
Avg Closing Trade (30 D):	$4.17M
Avg Closing Trade (90 D):	$2.47M
Avg Closing Volume:	187.78K

News

Feb 24, 2026 @ 1:31 PM Stock Market Today: S&P 500 Futures Slip As Dow, N... Source: Rishabh Mishra

Dec 7, 2025 @ 7:25 AM Is Alnylam Pharmaceuticals a Millionaire Maker? Source: Keith Speights

Aug 7, 2025 @ 4:32 AM Vir (VIR) Q2 Revenue Drops 61% Source: Jesterai

Jun 6, 2024 @ 5:29 PM Biotech Stock Roundup: GSK's Litigation Update, BI... Source: Zacks Equity Research

Jun 6, 2024 @ 5:26 PM Vir Biotechnology (VIR) Up on Positive Data From H... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.16	$-.3	$-3.16
Diluted EPS	$-3.16	$-.3	$-3.16
Revenue	$68.56M	$64.07M	$68.56M
Gross Profit	$68.53M		$68.53M
Net Income / Loss	$-437.99M	$-42.92M	$-437.99M
Operating Income / Loss	$-479.33M	$-47.92M	$-479.33M
Cost of Revenue	$.03M		$.03M
Net Cash Flow	$-77.63M	$61.81M	$-77.63M
PE Ratio